A federal election complaint filed on March 27, 2026, alleges that Rep. Alexandria Ocasio-Cortez misused nearly 19,000 dollars in campaign funds to pay for psychiatric services, raising questions about transparency and compliance with election law. The payments, made in 2025, are now under review by regulators.
The complaint, submitted by the National Legal and Policy Center to the Federal Election Commission and the Office of Congressional Conduct, claims the funds were reported as “leadership training and consulting” but instead went to psychiatrist Dr. Brian Boyle, known for ketamine therapy. Records show three payments totaling 18,725 dollars between March and October 2025.
Critics argue that the expenditures amount to personal use of campaign money, which is prohibited under federal law. They say the misreporting of expenses compounds the issue, suggesting an effort to conceal the true nature of the spending. Supporters of Ocasio-Cortez counter that the payments may have been legitimate consulting services tied to campaign leadership, though the complaint disputes that characterization.
The timing of the complaint has drawn attention, coming just months before the 2026 election cycle intensifies. Opponents have seized on the allegations as evidence of misconduct, while allies describe them as politically motivated attacks. The controversy has quickly spread across U.S. media outlets, with commentators debating whether the case reflects a serious violation or partisan maneuvering.
Public reaction has been divided. On social media, critics expressed outrage over the alleged misuse of funds, while supporters defended Ocasio-Cortez, pointing to her history of grassroots fundraising and transparency. International observers have noted the case as part of a broader conversation about accountability in U.S. politics, where campaign finance rules are often contested.
The Federal Election Commission is expected to review the complaint in the coming weeks. Whether the case results in penalties or dismissal will depend on how regulators interpret the evidence and reporting practices. For now, the allegations have added another layer of scrutiny to one of the most high-profile members of Congress, underscoring the ongoing tension between campaign finance law and political strategy.
